World AIDS Day: SAMRC's Groundbreaking Study with MGI's DNBSEQ Technology
12/1/23
Offline
South Africa
Share
On December 1st, we acknowledged World AIDS Day, reflecting on global efforts and advancements in HIV/AIDS research.
A SAMRC (South African Medical Research Council) study explored rare HIV phenotypes in South Africa using MGI's DNBSEQ technology, Identifying specific genetic variations that may contribute to their exceptional immune response opens doors to new therapeutic strategies and personalized treatments that could benefit millions of people living with HIV.
On December 1st, we acknowledged World AIDS Day, reflecting on global efforts and advancements in HIV/AIDS research.
A SAMRC (South African Medical Research Council) study explored rare HIV phenotypes in South Africa using MGI's DNBSEQ technology, Identifying specific genetic variations that may contribute to their exceptional immune response opens doors to new therapeutic strategies and personalized treatments that could benefit millions of people living with HIV.
On December 1st, we acknowledged World AIDS Day, reflecting on global efforts and advancements in HIV/AIDS research.
A SAMRC (South African Medical Research Council) study explored rare HIV phenotypes in South Africa using MGI's DNBSEQ technology, Identifying specific genetic variations that may contribute to their exceptional immune response opens doors to new therapeutic strategies and personalized treatments that could benefit millions of people living with HIV.
On December 1st, we acknowledged World AIDS Day, reflecting on global efforts and advancements in HIV/AIDS research.
A SAMRC (South African Medical Research Council) study explored rare HIV phenotypes in South Africa using MGI's DNBSEQ technology, Identifying specific genetic variations that may contribute to their exceptional immune response opens doors to new therapeutic strategies and personalized treatments that could benefit millions of people living with HIV.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
About SAMRC
Established in 1969, South African Medical Research Council (SAMRC) is dedicated to improving South Africa's health through research, innovation, and technology transfer, covering laboratory investigations, clinical research, and public health studies. Focused on the quadruple burden of disease, their research informs policy, enhances practices, and uplifts the nation's health. As the largest local funder, SAMRC pioneers cutting-edge medical innovations, addressing genomic research, treatment regimens, vaccine development, diagnostics, and drug/device creation. Committed to transformation, SAMRC addresses disparities through various programs, ensuring sustainable health research capacity in South Africa. As custodians of health research, SAMRC builds a healthier nation through ongoing innovation. For more information, please visit the samrc.ac.za.
About SAMRC
Established in 1969, South African Medical Research Council (SAMRC) is dedicated to improving South Africa's health through research, innovation, and technology transfer, covering laboratory investigations, clinical research, and public health studies. Focused on the quadruple burden of disease, their research informs policy, enhances practices, and uplifts the nation's health. As the largest local funder, SAMRC pioneers cutting-edge medical innovations, addressing genomic research, treatment regimens, vaccine development, diagnostics, and drug/device creation. Committed to transformation, SAMRC addresses disparities through various programs, ensuring sustainable health research capacity in South Africa. As custodians of health research, SAMRC builds a healthier nation through ongoing innovation. For more information, please visit the samrc.ac.za.
About SAMRC
Established in 1969, South African Medical Research Council (SAMRC) is dedicated to improving South Africa's health through research, innovation, and technology transfer, covering laboratory investigations, clinical research, and public health studies. Focused on the quadruple burden of disease, their research informs policy, enhances practices, and uplifts the nation's health. As the largest local funder, SAMRC pioneers cutting-edge medical innovations, addressing genomic research, treatment regimens, vaccine development, diagnostics, and drug/device creation. Committed to transformation, SAMRC addresses disparities through various programs, ensuring sustainable health research capacity in South Africa. As custodians of health research, SAMRC builds a healthier nation through ongoing innovation. For more information, please visit the samrc.ac.za.
About SAMRC
Established in 1969, South African Medical Research Council (SAMRC) is dedicated to improving South Africa's health through research, innovation, and technology transfer, covering laboratory investigations, clinical research, and public health studies. Focused on the quadruple burden of disease, their research informs policy, enhances practices, and uplifts the nation's health. As the largest local funder, SAMRC pioneers cutting-edge medical innovations, addressing genomic research, treatment regimens, vaccine development, diagnostics, and drug/device creation. Committed to transformation, SAMRC addresses disparities through various programs, ensuring sustainable health research capacity in South Africa. As custodians of health research, SAMRC builds a healthier nation through ongoing innovation. For more information, please visit the samrc.ac.za.
DNBSEQ
COLLABORATION
WORLD AIDS DAY
SAMRC
HIV
Share this article :
Share
Apr 24, 2025
Join us at ESHG 2025 and learn how MGI commits in advancing clinical and population genomics
From the launch of our latest sequencing platform DNBSEQ-T1+, to our cutting-edge single-cell and spatial transcriptomics workflows, we are showcasing how our integrated multi-omics solutions are shaping the future of clinical and population genomics.
Join us for our features Corporate Session, and don't miss the chance to explore our technologies live at booth #310.
May 20, 2025
Join us at SLAS Europe 2025 and discover our latest innovation
Join us at booth #516 and discover how we're driving innovation in labs. Don’t miss this opportunity to engage with our team, explore our latest technologies, and be part of the conversation shaping the future of life sciences.
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).